Citation Impact
Citing Papers
Yersinia pseudotuberculosis Effector YopJ Subverts the Nod2/RICK/TAK1 Pathway and Activates Caspase-1 to Induce Intestinal Barrier Dysfunction
2012
Percutaneous Radiofrequency Ablation versus Surgical Resection for the Treatment of Small Hepatic Carcinoma: A Meta-analysis
2016
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
PB1 Domain Interaction of p62/Sequestosome 1 and MEKK3 Regulates NF-κB Activation
2009
An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia
2006
Hepatocellular carcinoma
2018 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Cell type-specific function of TAK1 in innate immune signaling
2013
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
TNFR1‐induced activation of the classical NF‐κB pathway
2011
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
2017
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
2018
Hepatocellular carcinoma
2021 Standout
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
2011
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children
2016 Standout
Cancer-associated cachexia
2018 Standout
Role of the Helicobacter pylori‐Induced inflammatory response in the development of gastric cancer
2012
Selective autophagy mediated by autophagic adapter proteins
2011 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Insulin Receptor Signaling in Normal and Insulin-Resistant States
2014
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
2016
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Macrophage M1/M2 polarization
2020 Standout
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
2012
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
2013
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
2010
Toll-Like Receptor Signaling Pathways
2014 Standout
Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP)
2011
Hepatocellular carcinoma
2022 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
2010
Triggering MSR1 promotes JNK‐mediated inflammation in IL‐4‐activated macrophages
2019
Engineering allosteric regulation in protein kinases
2018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
2016
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β–triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination
2011
The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis
2016
Works of Ningling Ge being referenced
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma
2009
Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression
2008
Lysine 63-linked Polyubiquitination of TAK1 at Lysine 158 Is Required for Tumor Necrosis Factor α- and Interleukin-1β-induced IKK/NF-κB and JNK/AP-1 Activation
2009
Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis
2014
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study
2015
Phosphorylation of Thr-516 and Ser-520 in the Kinase Activation Loop of MEKK3 Is Required for Lysophosphatidic Acid-mediated Optimal IκB Kinase β (IKKβ)/Nuclear Factor-κB (NF-κB) Activation
2010
MEKK3 is required for lysophosphatidic acid-induced NF-κB activation
2009
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
2012
Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines
2003